Generic medicine

Neostigmine Methylsulphate 2.5mg/ml Injection

Reviewed educational reference: what Neostigmine Methylsulphate is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Neostigmine Methylsulphate
Strength
2.5mg/ml
Dosage form
Injection
Drug class
Cholinesterase inhibitor

Related products

No reviewed products are currently published for this generic.

Neostigmine methylsulphate is a potent, reversible acetylcholinesterase inhibitor used primarily in clinical settings to manage myasthenia gravis and to reverse the effects of non-depolarizing neuromuscular blocking agents. By inhibiting the enzyme responsible for the breakdown of acetylcholine, it increases the concentration and duration of action of this neurotransmitter at the neuromuscular junction. This action enhances muscle contraction and restores normal neuromuscular function in patients with specific neurological or surgical indications.

At a glance

Quick look

Neostigmine Methylsulphate is a synthetic cholinesterase inhibitor.

How it works

It increases acetylcholine levels to improve muscle function.

Who it is for

It is used for myasthenia gravis and surgical recovery.

Uses it for
Myasthenia gravisNeuromuscular blockade reversalUrinary retentionParalytic ileusMuscle weaknessPost-op care

Uses of Neostigmine Methylsulphate

  • Symptomatic treatment of myasthenia gravis.
  • Reversal of non-depolarizing neuromuscular blockade post-surgery.
  • Treatment of postoperative urinary retention.
  • Management of postoperative paralytic ileus.
  • Diagnostic aid for myasthenia gravis.
  • Prevention of postoperative abdominal distension.

Benefits of Neostigmine Methylsulphate

Restoration of Neuromuscular Function
The primary benefit of Neostigmine Methylsulphate is its ability to rapidly reverse the paralysis induced by non-depolarizing muscle relaxants. This is critical in the operating room to ensure that patients regain spontaneous breathing and muscle strength immediately after surgery, reducing the time spent on mechanical ventilation.

Symptomatic Relief in Myasthenia Gravis
For patients living with myasthenia gravis, Neostigmine Methylsulphate provides significant improvement in muscle strength and endurance. By maintaining higher levels of acetylcholine at the synaptic cleft, it helps overcome the autoimmune-mediated blockade of receptors, allowing patients to perform daily activities with greater ease and reduced fatigue.

Side effects of Neostigmine Methylsulphate

The administration of Neostigmine Methylsulphate can lead to cholinergic crisis or excessive stimulation of the parasympathetic nervous system. Common side effects include increased salivation, nausea, vomiting, abdominal cramps, and diarrhea. Patients may also experience bradycardia, hypotension, and increased bronchial secretions. In some cases, muscle fasciculations or weakness may occur if the dose is too high. Respiratory distress due to excessive secretions or bronchoconstriction is a serious concern that requires immediate medical attention. Ocular effects such as miosis and blurred vision are also frequently reported during treatment.

Side effectHow commonHow severeWhat to do
BradycardiaCommonModerateAdminister atropine as prescribed.
Abdominal crampsVery commonMildAdjust dose if necessary.
Respiratory distressRareSevereProvide oxygen and suction.

How to manage side effects

Bradycardia

  • 1. Assess heart rate.
  • 2. Administer atropine.
  • 3. Monitor ECG.

Abdominal cramps

  • 1. Evaluate dietary intake.
  • 2. Consult doctor for dose adjustment.
  • 3. Monitor bowel frequency.

Respiratory distress

  • 1. Clear airway.
  • 2. Administer oxygen.
  • 3. Seek emergency medical care.

How to use Neostigmine Methylsulphate

  • Neostigmine Methylsulphate 2.5mg/ml Injection is administered strictly by a healthcare professional via intravenous, intramuscular, or subcutaneous injection.
  • The dosage is highly individualized based on the patient's response and the specific clinical condition being treated.
  • Continuous monitoring of vital signs, including heart rate and respiratory function, is mandatory during and after administration.
  • Atropine should always be readily available to counteract potential muscarinic side effects like severe bradycardia.

Special population advice

Kidney impairment

  • Reduce dose based on creatinine clearance.
  • Monitor for prolonged effects.

Liver impairment

  • Use with caution.
  • Monitor liver function periodically.

Children

  • Dose based on body weight.
  • Strict medical supervision required.

Elderly

  • Start with lower doses.
  • Monitor for cardiac side effects.

How Neostigmine Methylsulphate works

Neostigmine Methylsulphate works by reversibly binding to the active site of the enzyme acetylcholinesterase. This prevents the enzyme from hydrolyzing acetylcholine into choline and acetic acid. As a result, acetylcholine accumulates in the synaptic cleft, prolonging its stimulatory effect on nicotinic and muscarinic receptors. This enhanced cholinergic transmission improves muscle tone and restores neuromuscular transmission.

What if you miss or exceed a dose?

If you miss a dose

Since Neostigmine Methylsulphate 2.5mg/ml Injection is administered by a healthcare professional in a clinical setting, missed doses are unlikely. If you are receiving scheduled injections for myasthenia gravis, ensure you keep all appointments. If a dose is missed, contact your doctor immediately to reschedule.

In case of overdose

An overdose of Neostigmine Methylsulphate leads to a cholinergic crisis, characterized by extreme muscle weakness, excessive sweating, salivation, miosis, bradycardia, and respiratory failure. This is a medical emergency. Treatment involves immediate cessation of the drug, airway management, and the administration of atropine to block muscarinic effects.

AntidoteAtropine Sulphate

Atropine is used to block the muscarinic effects of neostigmine overdose.

Respiratory support
Provide mechanical ventilation if respiratory paralysis occurs.
Atropine administration
Administer 0.6-1.2 mg IV to reverse muscarinic symptoms.
Monitoring
Continuous ECG and pulse oximetry until stable.
Supportive care
Manage hypotension and maintain fluid balance.

Safety and precautions

When to avoid Neostigmine Methylsulphate

Do not take if you
  • Mechanical obstruction

    Do not use in patients with mechanical intestinal or urinary obstruction.

  • Hypersensitivity

    Contraindicated in patients with known allergy to the drug.

Use with caution
  • Asthma

    May cause bronchoconstriction.

  • Bradycardia

    May worsen heart rate issues.

  • Peptic ulcer

    May increase gastric acid secretion.

  • Epilepsy

    May lower seizure threshold.

Safety at a glance

AlcoholConsult your doctor

Alcohol may exacerbate dizziness and muscle weakness; avoid consumption.

PregnancyUse with caution

Use only if the potential benefit justifies the risk to the fetus.

BreastfeedingUse with caution

Consult your doctor; it is unknown if the drug passes into breast milk.

DrivingUse with caution

Avoid driving if you experience blurred vision or muscle weakness.

KidneyUse with caution

Dose adjustment may be required in patients with renal impairment.

LiverUse with caution

Use with caution in patients with hepatic dysfunction.

AllergyUnsafe

Do not use if you have a known hypersensitivity to neostigmine.

ChildrenUse with caution

Use strictly under pediatric specialist supervision.

ElderlyUse with caution

Elderly patients are more sensitive to cholinergic side effects.

Interactions

With other medicines

Aminoglycosides

Moderate

Changes the medicine’s effect

What can happen: Reduced muscle strength improvement.

What to do: Monitor patient closely for signs of weakness.

Succinylcholine

Major

Changes the medicine’s effect

What can happen: Prolonged neuromuscular blockade.

What to do: Avoid concurrent use or monitor with nerve stimulator.

Beta-blockers

Moderate

Changes the medicine’s effect

What can happen: Increased risk of bradycardia.

What to do: Monitor heart rate and blood pressure.

With food and drink

  • None specificMinor

    No direct food interactions are documented for the injectable form.

  • Alcohol beveragesModerate

    Alcohol may increase CNS depression and dizziness when combined with therapy.

If you have another condition

  • Asthma

    Increased risk of bronchospasm.

  • Cardiac arrhythmias

    Risk of worsening heart rhythm.

Effect on laboratory tests

  • Serum cholinesterase

    Decreased levels

    The drug inhibits the enzyme, leading to lower measured activity.

Quick tips

  • Always inform your surgeon or anesthetist about your history of asthma or heart disease before receiving this injection.
  • Keep a record of your muscle strength improvements to help your doctor adjust your dosage.
  • Report any sudden increase in saliva or difficulty breathing immediately to the nursing staff.
  • Do not attempt to self-administer this medication under any circumstances.
  • Ensure you are monitored for at least 30 minutes after the injection to watch for delayed adverse reactions.

Counselling points

  • MonitoringImportant

    You will be closely monitored for breathing and heart rate after the injection.

  • Side effectsImportant

    Report any stomach cramps or excessive saliva immediately.

  • Follow-upGood to know

    Keep all follow-up appointments to assess your muscle strength.

Monitoring during treatment

Before starting

  • Heart rate
  • Blood pressure
  • Respiratory rate

During treatment

  • every dose: Monitor muscle strength and respiratory effort

What is being watched

  • Heart rate
  • Oxygen saturation
  • Muscle power

Pharmacokinetics

Absorption
Rapidly absorbed after IM/SC injection.
Bioavailability
Variable depending on route.
Protein binding
15-25%.
Volume of distribution
0.7-1.4 L/kg.
Half-life
45-90 minutes.
Metabolism
Hepatic via hydrolysis.
Excretion
Renal (approx 80% as metabolites).
Onset / duration
Onset 2-5 min (IV); Duration 2-4 hours.

Fact box

Chemical class
Quaternary ammonium compound
Habit forming
No
Therapeutic class
Antimyasthenic agent
Action class
Reversible acetylcholinesterase inhibitor
Storage
Store between 20°C and 25°C. Protect from light. Do not freeze. Keep out of reach of children.
ATC code
N07AA01
Pregnancy category
C

More information

Clinical Rationale for Neostigmine Use

Clinicians prioritize Neostigmine Methylsulphate in the perioperative setting because of its rapid and predictable onset of action. When a patient is under general anesthesia, neuromuscular blocking agents are used to paralyze muscles for surgery. Once the procedure is complete, the patient must regain control of their diaphragm and intercostal muscles to breathe independently. Neostigmine Methylsulphate effectively reverses this paralysis by flooding the neuromuscular junction with acetylcholine, which outcompetes the blocking agent. This transition is vital for patient safety and facilitates a smoother recovery from anesthesia.

Comparison with Alternative Agents

While Neostigmine Methylsulphate is a standard choice, clinicians also consider alternatives like Sugammadex for specific types of neuromuscular blockade. Unlike Neostigmine Methylsulphate, which acts by increasing acetylcholine, Sugammadex works by encapsulating the blocking agent itself. However, Neostigmine Methylsulphate remains a cost-effective and widely used option, particularly in resource-limited settings. Its long history of use and well-understood profile make it a reliable tool in the hands of experienced anesthesiologists who are adept at managing its muscarinic side effects with concurrent atropine.

Lifestyle and Management During Treatment

For patients managing myasthenia gravis with Neostigmine Methylsulphate, lifestyle adjustments are essential. Because the drug's effect is temporary, patients must time their doses carefully to coincide with periods of high activity, such as mealtimes or physical therapy. It is also important to maintain a diary of muscle strength to help the physician fine-tune the dosage. Patients should avoid extreme heat and stress, as these can worsen the symptoms of myasthenia gravis and potentially reduce the effectiveness of the medication.

Common Misconceptions and Safety

A common misconception is that Neostigmine Methylsulphate provides a permanent cure for muscle weakness. It is important to understand that this medication only provides symptomatic relief by enhancing nerve-to-muscle signaling. It does not address the underlying autoimmune cause of myasthenia gravis. Furthermore, patients often fear the side effects associated with cholinergic stimulation. While these effects like salivation and cramping can be uncomfortable, they are predictable and easily managed by a skilled medical team. Always trust the clinical judgment of your doctor regarding the necessity of this treatment.

References

  1. Drugs.com. Neostigmine Methylsulfate Injection.View sourceAccessed
  2. FDA. Neostigmine Methylsulfate Injection Label.View sourceAccessed
  3. DailyMed. Neostigmine Methylsulfate Injection.View sourceAccessed
  4. Electronic Medicines Compendium. Neostigmine Methylsulphate Injection.View sourceAccessed
  5. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed

Frequently asked questions about Neostigmine Methylsulphate

What is the main use of Neostigmine?

It is used to treat myasthenia gravis and to reverse muscle relaxation after surgery.

Is Neostigmine safe for everyone?

No, it is contraindicated in patients with mechanical bowel or urinary obstruction.

How is the injection administered?

It is given by a healthcare professional via IV, IM, or subcutaneous routes.

What should I do if I feel weak after the injection?

Report it immediately to your nurse or doctor, as it may indicate a cholinergic crisis.

Can I take other medicines with Neostigmine?

Only if your doctor approves, as many drugs can interact with its action.

Latest